Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117520863 | 11752086 | 3 | F | 20160726 | 20151118 | 20160802 | EXP | US-ELI_LILLY_AND_COMPANY-US201511003628 | ELI LILLY AND CO | 77.00 | YR | F | Y | 0.00000 | 20160802 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
117520863 | 11752086 | 1 | PS | ADCIRCA | TADALAFIL | 1 | Oral | 40 MG, QD | Y | Y | 21368 | 40 | MG | TABLET | QD | ||||
117520863 | 11752086 | 2 | SS | ADCIRCA | TADALAFIL | 1 | Oral | 40 MG, QD | Y | Y | 21368 | 40 | MG | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
117520863 | 11752086 | 1 | Pulmonary arterial hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
117520863 | 11752086 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
117520863 | 11752086 | Cardiac failure congestive | |
117520863 | 11752086 | Drug intolerance | |
117520863 | 11752086 | Pulmonary arterial hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
117520863 | 11752086 | 1 | 20150918 | 0 | ||
117520863 | 11752086 | 2 | 201510 | 0 |